Dld Asset Management, LP Athira Pharma, Inc. Put Options Transaction History

Dld Asset Management, LP

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 12, 2022	SELL	$2.74 - $13.43 $176,730 - $866,235	-64,500 Reduced 86.0%	10,500 $32,000
Q1 2022 May 13, 2022	SELL	$8.96 - $13.51 $32,256 - $48,636	-3,600 Reduced 4.58%	75,000 $1.01 Million
Q4 2021 Feb 22, 2022	SELL	$9.17 - $16.39 $71.4 Million - $128 Million	-7,781,400 Reduced 99.0%	78,600 $1.03 Million
Q4 2021 Feb 14, 2022	BUY	$9.17 - $16.39 $72.1 Million - $129 Million	7,860,000 New	7,860,000 $1.03 Million

16.9M

112K

68K

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $21.6M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

Get notified when there are updates to the investment portfolio of Dld Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Dld Asset Management, LP with notifications on news.